Elecsys HBeAg Immunoassay, Elecysys PreciControl HBeAg Approved for Marketing

The U.S. Food and Drug Administration has given approval to Indianapolis-based Roche Diagnostics to market its Hepatitis B test kit.

Advertisement

The test kit, Elecsys HBeAg Immunoassay is a lab test used to detect human Hepatitis B e antigen that is associated with the Hepatitis B virus infection. The Elecsys PreciControl HBeAg is a quality control that ensures the test is properly working.

More Articles on FDA Approvals:

FDA Approves Alprolix for Hemophilia B Treatment
FDA Approves Otezla for Psoriatic Arthritis Treatment
FDA Approves Xolair for Chronic Hives

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Rethinking Safety and Security in the Healthcare Environment

Thursday, July 23
1:00 PM - 2:00 PM CDT

Presenters: Jon Share, AxonDan Snyder, Advocate HealthKeith Hunter, Wellstar

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.